Adler A, Bergwik J, Padra M, Papareddy P, Schmidt T, Dahlgren M
Respir Res. 2025; 26(1):101.
PMID: 40087604
DOI: 10.1186/s12931-025-03175-z.
Xi Y, Xu R, Chen S, Fang J, Duan X, Zhang Y
Cell Death Dis. 2024; 15(11):838.
PMID: 39551802
PMC: 11570632.
DOI: 10.1038/s41419-024-07229-w.
Tsourmas K, Butler C, Kwang N, Sloane Z, Dykman K, Maloof G
bioRxiv. 2024; .
PMID: 39484433
PMC: 11526954.
DOI: 10.1101/2024.10.21.619538.
Mo X, Rao D, Kaur K, Hassan R, Abdel-Samea A, Farhan S
Molecules. 2024; 29(19).
PMID: 39407697
PMC: 11477627.
DOI: 10.3390/molecules29194770.
Masum A, Aoki S, Rahman M, Hisamatsu Y
RSC Med Chem. 2024; .
PMID: 39246747
PMC: 11376135.
DOI: 10.1039/d4md00183d.
Exploring the potential of Ziziphus nummularia and luteolin-7-O-glucoside as tubulin inhibitors in cancer therapy and survival.
Alghamdi S, Alghashem S, Ali R, Alsubait A, Suliman R, Mohammed A
Sci Rep. 2024; 14(1):7202.
PMID: 38531974
PMC: 10966015.
DOI: 10.1038/s41598-024-57680-0.
A Recipe for Successful Metastasis: Transition and Migratory Modes of Ovarian Cancer Cells.
Sliwa A, Szczerba A, Pieta P, Bialas P, Lorek J, Nowak-Markwitz E
Cancers (Basel). 2024; 16(4).
PMID: 38398174
PMC: 10886816.
DOI: 10.3390/cancers16040783.
(S)-3-(3-Fluoro-4-Methoxybenzyl)-5,6,7-Trimethoxychroman-4-One Suppresses the Proliferation of Huh7 Cells by Up-regulating P21 and Inducing G/M Phase Arrest.
Yoon H, Lee J, Kwon S, Seo S, Cho S
Cancer Genomics Proteomics. 2023; 20(6suppl):754-762.
PMID: 38035711
PMC: 10687728.
DOI: 10.21873/cgp.20422.
Nanoscale Phytosomes as an Emerging Modality for Cancer Therapy.
Kadriya A, Falah M
Cells. 2023; 12(15).
PMID: 37566078
PMC: 10417745.
DOI: 10.3390/cells12151999.
The short-chain fatty acid acetate coordinates with CD30 to modulate T-cell survival.
Lyu J, Li Z, Roberts J, Qi Y, Xiong J
Mol Biol Cell. 2023; 34(8):br11.
PMID: 37163337
PMC: 10398883.
DOI: 10.1091/mbc.E23-01-0032.
Design, synthesis, and anticancer evaluation of 1-benzo[1,3]dioxol-5-yl-3-N-fused heteroaryl indoles.
Yao C, Wu M, Chang P, Wu S, Song J, Huang H
Mol Divers. 2023; 28(2):595-608.
PMID: 36735167
DOI: 10.1007/s11030-023-10605-x.
In Vivo Inhibitory Assessment of Potential Antifungal Agents on Proliferation in Honey Bees.
Bahreini R, Nasr M, Docherty C, de Herdt O, Feindel D, Muirhead S
Pathogens. 2022; 11(11).
PMID: 36422626
PMC: 9695399.
DOI: 10.3390/pathogens11111375.
A new host-targeted antiviral cyclolignan (SAU-22.107) for Dengue Virus infection in cell cultures. Potential action mechanisms based on cell imaging.
Brand Y, Roa-Linares V, Santiago-Dugarte C, Olmo E, Lopez-Perez J, Betancur-Galvis L
Virus Res. 2022; 323:198995.
PMID: 36336130
PMC: 10194330.
DOI: 10.1016/j.virusres.2022.198995.
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities.
Romagnoli R, Oliva P, Prencipe F, Manfredini S, Budassi F, Brancale A
Pharmaceuticals (Basel). 2022; 15(8).
PMID: 36015179
PMC: 9415608.
DOI: 10.3390/ph15081031.
Design, synthesis, and biological screening of a series of 4'-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs).
Riu F, Ibba R, Zoroddu S, Sestito S, Lai M, Piras S
J Enzyme Inhib Med Chem. 2022; 37(1):2223-2240.
PMID: 35979600
PMC: 9397482.
DOI: 10.1080/14756366.2022.2111680.
Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents.
Oliva P, Romagnoli R, Cacciari B, Manfredini S, Padroni C, Brancale A
Pharmaceutics. 2022; 14(6).
PMID: 35745764
PMC: 9230136.
DOI: 10.3390/pharmaceutics14061191.
Anticancer mechanism of 7-α-hydroxyfrullanolide on microtubules and computational prediction of its target binding in triple-negative breast cancer cells.
Chimplee S, Smythe C, Tipmanee V, Sukrong S, Kanokwiroon K
PeerJ. 2022; 10:e13508.
PMID: 35651747
PMC: 9150694.
DOI: 10.7717/peerj.13508.
A Novel Docetaxel-Biotin Chemical Conjugate for Prostate Cancer Treatment.
Rayan M, Shadafny S, Falah A, Falah M, Abu-Lafi S, Asli S
Molecules. 2022; 27(3).
PMID: 35164226
PMC: 8839329.
DOI: 10.3390/molecules27030961.
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment.
Tymon-Rosario J, Adjei N, Roque D, Santin A
Cancers (Basel). 2021; 13(24).
PMID: 34944858
PMC: 8699494.
DOI: 10.3390/cancers13246239.
Therapeutic potential of marine peptides in cervical and ovarian cancers.
Ahmed S, Khan H, Fakhri S, Aschner M, Cheang W
Mol Cell Biochem. 2021; 477(2):605-619.
PMID: 34855045
DOI: 10.1007/s11010-021-04306-y.